View in EDS PDF Full Text

Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.

Saved in:
Bibliographic Details
Title: Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.
Authors: Brett JO; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA., Ritterhouse LL; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Newman ET; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Department of Orthopedic Surgery, Harvard Medical School, Boston, MA, USA., Irwin KE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Department of Psychiatry, Harvard Medical School, Boston, MA, USA., Dawson M; Massachusetts General Hospital Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; University of Michigan Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA., Ryan LY; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Spring LM; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Rivera MN; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Lennerz JK; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Dias-Santagata D; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Bardia A; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Wander SA; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Source: The oncologist [Oncologist] 2023 Feb 08; Vol. 28 (2), pp. 172-179.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36493359
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brett+JO%22">Brett JO</searchLink>; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ritterhouse+LL%22">Ritterhouse LL</searchLink>; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Newman+ET%22">Newman ET</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Department of Orthopedic Surgery, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Irwin+KE%22">Irwin KE</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Department of Psychiatry, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dawson+M%22">Dawson M</searchLink>; Massachusetts General Hospital Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; University of Michigan Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+LY%22">Ryan LY</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Spring+LM%22">Spring LM</searchLink>; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rivera+MN%22">Rivera MN</searchLink>; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lennerz+JK%22">Lennerz JK</searchLink>; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dias-Santagata+D%22">Dias-Santagata D</searchLink>; Massachusetts General Hospital Department of Pathology, Center for Integrated Diagnostics, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ellisen+LW%22">Ellisen LW</searchLink>; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bardia+A%22">Bardia A</searchLink>; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wander+SA%22">Wander SA</searchLink>; Massachusetts General Hospital Department of Medicine, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2023 Feb 08; Vol. 28 (2), pp. 172-179.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36493359
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/oncolo/oyac248
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 172
    Titles:
      – TitleFull: Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brett JO
      – PersonEntity:
          Name:
            NameFull: Ritterhouse LL
      – PersonEntity:
          Name:
            NameFull: Newman ET
      – PersonEntity:
          Name:
            NameFull: Irwin KE
      – PersonEntity:
          Name:
            NameFull: Dawson M
      – PersonEntity:
          Name:
            NameFull: Ryan LY
      – PersonEntity:
          Name:
            NameFull: Spring LM
      – PersonEntity:
          Name:
            NameFull: Rivera MN
      – PersonEntity:
          Name:
            NameFull: Lennerz JK
      – PersonEntity:
          Name:
            NameFull: Dias-Santagata D
      – PersonEntity:
          Name:
            NameFull: Ellisen LW
      – PersonEntity:
          Name:
            NameFull: Bardia A
      – PersonEntity:
          Name:
            NameFull: Wander SA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 02
              Text: 2023 Feb 08
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1